Dose in (Adjuvant) Chemotherapy of Breast Cancer

L Norton, R Simon, The Norton-Simon hypothesis revisited. Cancer treatment reports. ,vol. 70, pp. 163- 169 ,(1986)

Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95. Journal of Clinical Oncology. ,vol. 24, pp. 370- 378 ,(2006) , 10.1200/JCO.2005.03.5196

E. Engelsman, J.C.M. Klijn, R.D. Rubens, J. Wildiers, L.V.A.M. Beex, M.A. Nooij, N. Rotmensz, R. Sylvester, “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer European Journal of Cancer and Clinical Oncology. ,vol. 27, pp. 966- 970 ,(1991) , 10.1016/0277-5379(91)90259-G

A M Gianni, S Siena, M Bregni, M Di Nicola, S Orefice, F Cusumano, B Salvadori, A Luini, M Greco, R Zucali, F Rilke, M Zambetti, P Valagussa, G Bonadonna, Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results. Journal of Clinical Oncology. ,vol. 15, pp. 2312- 2321 ,(1997) , 10.1200/JCO.1997.15.6.2312

Martine J. Piccart, Angelo Di Leo, Marc Beauduin, Anita Vindevoghel, Jacques Michel, Christian Focan, Alain Tagnon, Fernand Ries, Philippe Gobert, Claude Finet, Marie T. Closon-Dejardin, Jean P. Dufrane, Joseph Kerger, Françoise Liebens, Sylvie Beauvois, Sylvie Bartholomeus, Stella Dolci, Jean P. Lobelle, Marianne Paesmans, Jean M. Nogaret, Phase III Trial Comparing Two Dose Levels of Epirubicin Combined With Cyclophosphamide With Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer Journal of Clinical Oncology. ,vol. 19, pp. 3103- 3110 ,(2001) , 10.1200/JCO.2001.19.12.3103

B Fisher, S Anderson, D L Wickerham, A DeCillis, N Dimitrov, E Mamounas, N Wolmark, R Pugh, J N Atkins, F J Meyers, N Abramson, J Wolter, R S Bornstein, L Levy, E H Romond, V Caggiano, M Grimaldi, P Jochimsen, P Deckers, Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. Journal of Clinical Oncology. ,vol. 15, pp. 1858- 1869 ,(1997) , 10.1200/JCO.1997.15.5.1858

Sjoerd Rodenhuis, Marijke Bontenbal, Louk V.A.M. Beex, John Wagstaff, Dick J. Richel, Marianne A. Nooij, Emile E. Voest, Pierre Hupperets, Harm van Tinteren, Hans L. Peterse, Elisabeth M. TenVergert, Elisabeth G.E. de Vries, High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer The New England Journal of Medicine. ,vol. 349, pp. 7- 16 ,(2003) , 10.1056/NEJMOA022794

Halle C.F. Moore, Stephanie J. Green, Julie R. Gralow, Scott I. Bearman, Danika Lew, William E. Barlow, Clifford Hudis, Antonio C. Wolff, James N. Ingle, Helen K. Chew, Anthony D. Elias, Robert B. Livingston, Silvana Martino, Intensive Dose-Dense Compared With High-Dose Adjuvant Chemotherapy for High-Risk Operable Breast Cancer: Southwest Oncology Group/Intergroup Study 9623 Journal of Clinical Oncology. ,vol. 25, pp. 1677- 1682 ,(2007) , 10.1200/JCO.2006.08.9383

Janet Fricker, San Antonio Breast Cancer Symposium. Lancet Oncology. ,vol. 10, pp. 20- ,(2009) , 10.1016/S1470-2045(08)70329-2

Martin S. Tallman, Robert Gray, Nicholas J. Robert, Charles F. LeMaistre, C. Kent Osborne, William P. Vaughan, William J. Gradishar, Thomas M. Pisansky, John Fetting, Elisabeth Paietta, Hillard M. Lazarus, Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer New England Journal of Medicine. ,vol. 349, pp. 17- 26 ,(2003) , 10.1056/NEJMOA030684